Atherogenic alterations in hypertriglyceridemic patients would not depend on insulin resistance

Autor: Leonardo Gómez Rosso, Gustavo Giunta, Fernando Brites, Tomás Meroño, Luis Cuniberti, Laura Boero, Laura Schreier
Rok vydání: 2012
Předmět:
Zdroj: Clinica Chimica Acta. 413:620-624
ISSN: 0009-8981
Popis: Background and aims Several studies have been carried out to characterize the different alterations associated with hypertriglyceridemia (HTG) and to identify this dyslipemia as an independent risk factor for cardiovascular disease (CVD). HTG is frequently, but not always, associated with insulin resistance (IR). The present study was aimed to evaluate if the alterations observed in biomarkers of CVD were similar in HTG states independently of IR. Methods HTG was defined as triglycerides ≥1.69 mmol/l and IR as HOMA-IR ≥3.1. HTG-IR patients (n = 15) were compared with HTG subjects without IR (WIR) (n = 15) and with normotriglyceridemic (NTG)-WIR individuals (n = 30). Results Both HTG groups shared the increment in VLDL-C and non-HDL-C, HDL enrichment in triglycerides and depletion in phospholipids, the decrease in adiponectin concentration, and the increase in CETP activity. HDL-C and VCAM-1 levels were altered only in HTG-IR patients in comparison with the other groups, while oxidized LDL was only higher in HTG-IR than the control group. Multiple regression analysis identified triglycerides as the independent predictor of HDL-C, CETP activity and oxidized LDL levels. Conclusion The increase in triglycerides is the major determinant factor of the atherogenic modifications observed, while IR would be an amplifier factor.
Databáze: OpenAIRE
Externí odkaz: